Cargando…
Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
Cancer therapeutic vaccine can induce antigen-specific immune response, which has shown great potential in cancer immunotherapy. As the key factor of vaccine, antigen plays a central role in eliciting antitumor immunity. However, the insufficient antigen delivery and low efficiency of antigen presen...
Autores principales: | Shi, Chen, Jian, Chen, Wang, Lulu, Gao, Chen, Yang, Ting, Fu, Zhiwen, Wu, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521411/ https://www.ncbi.nlm.nih.gov/pubmed/37752555 http://dx.doi.org/10.1186/s12951-023-02106-8 |
Ejemplares similares
-
Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
por: Shi, Chen, et al.
Publicado: (2023) -
Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy
por: Chen, Hu, et al.
Publicado: (2022) -
A STING-Activating Nanovaccine for Cancer Immunotherapy
por: Luo, Min, et al.
Publicado: (2017) -
CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen, Wenqiang, et al.
Publicado: (2021) -
In Situ Cocktail Nanovaccine for Cancer Immunotherapy
por: Liu, Mohan, et al.
Publicado: (2023)